Taurine Deficiency and MELAS Are Closely Related Syndromes - Advances in Experimental Medicine and Biology - page 153

Rummelt V, Folberg R, Ionasescu V, Yi H, Moore KC (1993) Ocular pathology of MELAS
syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology
100:1757-1766
Schaffer SW, Wilson GL (1993) Insulin resistance and mechanical dysfunction in hearts of Wistar
rats with streptozotocin-induced non-insulin-dependent diabetes mellitus. Diabetologia
36:195-199
Schmidt SY, Berson EL, Watson G, Huang C (1977) Retinal degeation in cats fed casein III.
Taurine deficiency and ERG amplitudes. Invest Ophthalmol Visual Sci 16:673-678
Sergeeva OA, Fleischer W, Chepkova AN, Warskulat U, Haussinger D, Siebler M, Hess HL (2007)
GABA A -receptor modification in taurine transporter knockout mice causes striatal disinhibi-
tion. J Physiol 585:539-548
Silbert L, Durocher A, Biller J (1996) The “S” in MELAS. J Stroke Cerebrovasc Dis 6:67-71
Smith PR, Bain SC, Good PA, Hattersley AT, Barnett AH, Gibson JM, Dodson PM (1999)
Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness
caused by the mitochondrial DNA 3243 tRNA Leu A to G mutation. Ophthalmology
106:1101-1108
Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis and strokelike
episodes: Basic concepts, clinical phenotype, and therapeutic management of MELAS syn-
drome. Ann N Y Acad Sci 1142:133-158
Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, DeVivo DC (2007) Wolff-Parkinson-
White syndrome in patients with MELAS. Arch Neurol 64:1625-1627
Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, Jean-Francois MJB,
Byrne E, Morris JGL (1998) Neuroradiological features of six kindreds with MELAS tRNA Leu
A3243G point mutation: implications for pathogenesis. J Neurl Neurosug Psychiatry
65:233-240
Thambisetty M, Newman NJ, Glass JD, Frankel MR (2002) A practical approach to the diagnosis
and management of MELAS: case report and review. Neurologist 8:302-312
Trachtman H, Barbour R, Sturman JA, Finberg L (1988) Taurine and osmoregulation: Taurine is a
cerebral osmoprotective molecular in chronic hypernatremic dehydration. Pediatr Res
23:35-39
Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E, Sturman JA (1992)
Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J
Physiol 262:F117-F123
Turnbull HE, Lax NZ, Diodato D, Ansorge O, Turnbull DM (2010) The mitochondrial brain: From
mitochondrial genome to neurodegeneration. Biochim Biophys Acta 1802:111-121
Tyson JE, Lasky R, Flood D, Mize C, Picone T, Paule CL (1989) Randomized trial of taurine
supplementation for infants<1,300-gram birth weight: effect on auditory brainstem-evoked
responses. Pediatrics 83:406-415
Vallecalle-Sandoval MH, Heaney G, Sersen E, Sturman JA (1991) Comparison of the developmen-
tal changes of the brainstem auditory evoked response (BAER) in taurine-supplemented and
taurine-deficient kittens. Int J Dev Neurosci 9:571-579
Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg
PAA, van de Kamp JJP, Maaseen JA (1992) Mutation in mitochondrial tRNA Leu(UUR) gene in a
large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet
1:368-371
Vinton NE, Heckenlively JR, Laidlaw SA, Martin DA, Foxman SR, Ament ME, Kopple JD (1990)
Visual function in patients undergoing long-term total parenteral nutrition. Am J Clin Nutr
52:895-902
Vionnet N, Passa P, Froguel P (1993) Prevalence of mitochondrial gene mutations in families with
diabetes mellitus. Lancet 342:1429-1430
Warskulat U, Borsch E, Reinehr R, Heller-Stilb B, Monnighoff I, BuchczykD DM, Flogel U,
Kappert G, Soboll S, Beer S, Pfeffer K, Marschall HU, Gabrielsen M, Amiry-Moghaddam M,
Ottersen OP, Dienes HP, Haussinger D (2006) Chronic liver disease is triggered by taurine
transporter knockout in the mouse. FASEB J 20:574-576